Lectin affinity chromatography is a powerful separation technique that fractionates proteins by selectively binding to specific carbohydrate moieties characteristic of protein glycosylation type. Wheat germ agglutinin (WGA) selectively binds terminal N-acetylglucosamine (O-GlcNAc) and sialic acid moieties characteristic of O-linked glycosylation. The current study utilizes WGA affinity chromatography to fractionate proteins from hippocampus and inferior parietal lobule (IPL) from subjects with Alzheimer's disease (AD) and arguably its earliest form, mild cognitive impairment (MCI). Proteins identified by proteomics that were fractionated from MCI and AD hippocampus by WGA affinity chromatography with altered levels compared with age-matched controls included GP96, g-enolase, glutamate dehydrogenase, glucosidase IIa, 14-3-3e, 14-3-3g, 14-3-3f, tropomyosin-2, calmodulin 2, gelsolin, b-synuclein, a1-antichymotrypsin, and dimethylguanosine tRNA methyltransferase. Proteins identified by proteomics that were fractionated from MCI and AD IPL by WGA affinity chromatography showing altered levels compared with age-matched controls included protein disulfide isomerase, calreticulin, and GP96. The proteins described in this study are involved in diverse processes, including glucose metabolism, endoplasmic reticulum (ER) functions, chaperoning, cytoskeletal assembly, and proteolysis, all of which are affected in AD. This study, the first to use proteomics to identify WGA-fractionated proteins isolated from brains from subjects with MCI and AD, provides additional information about the active proteome of the brain throughout AD progression. V V C 2010 Wiley-Liss, Inc.
Alzheimer's disease (AD) is a neurodegenerative disorder that currently affects 5.3 million Americans and in the absence of interventions to slow or halt progression of this dementing disorder is predicted to affect 16-20 million Americans in just a few decades (Mebane-Sims, 2009) . AD is the most common cause of dementia and is characterized pathologically by the occurrence of neurofibrillary tangles (NFTs) and senile plaques (SPs) in the neocortex, entorhinal cortex, and hippocampus (Markesbery, 1997) . In addition, the aforementioned brain regions as well as hippocampal efferents to the inferior parietal lobule (IPL) are dramatically atrophied in AD brain compared with the brains from nondemented subjects (Clower et al., 2001) . NFTs occur intracellularly and feature paired helical filament (PHF) structures composed of hyperphosphorylated tau, whereas senile plaques are extracellular and are composed primarily of amyloid-beta peptides (Abs). Abs contained in SPs range between 39 and 43 amino acids in length, the Ab 1-42 variant being the dominant form present in the plaques (Selkoe, 2004) . Amnestic mild cognitive impairment (aMCI) is arguably the earliest form of AD. aMCI patients have detectable deficits in speech, memory, or other essential cognitive abilities but no dementia; however, these deficits do not interfere with activities of daily living (Mebane-Sims, 2009 ). Estimates suggest that 10-20% of the population aged 65 and older has aMCI, and a significant portion of aMCI patients progresses further to AD (Mebane-Sims, 2009 ). The clinical involvement of patients diagnosed with aMCI is a vital focus of AD research.
Protein glycosylation is a posttranslational modification (PTM) that affects proteins in a variety of ways, including proper protein folding, protein function regulation, and cellular localization. Protein glycosylation occurs in two general forms, N-linked glycosylation and O-linked glycosylation. N-linked glycosylation occurs in the endomembrane system and has a canonical serine/threonine (Ser/Thr)-X-asparagine (Asn) motif to which glycans are added to the Asn residue. O-linked glycosylation is the addition of carbohydrates to Ser or Thr residues; however, O-linked glycosylation sites do not have a well-characterized motif for glycan addition. O-linked glycosylation has traditionally been thought to occur only in the Golgi apparatus as part of the secretory pathway, but studies show that O-linked glycosylation occurs on cytoplasmic and nucleoplasmic proteins through the addition of a single N-acetylglucosamine (O-GlcNAc) residue to Ser/Thr (Hart, 1997; Hart et al., 2007) . The exact role of nonsecretory pathway O-linked glycosylation is unknown, but studies suggest that nucleoplasmic and cytoplasmic O-linked glycosylation works in concert with phosphorylation to regulate proteins (Hart et al., 2007) . Additionally, nonsecretory pathway O-link glycosylation has been hypothesized to function as a cellular glucose sensor (Lefebvre et al., 2010) . Levels of nonsecretory pathway O-linked glycosylation are decreased globally in AD, including levels of O-GlcNAc modified tau protein (Liu et al., 2004) .
Lectin affinity chromatography is a powerful separation technique that fractionates proteins by selectively binding to specific carbohydrate moieties characteristic of protein glycosylation type. Concanavalin-A (ConA) and wheat germ agglutinin (WGA) are the two most widely used lectins for chromatographic separations. ConA has affinity for high-mannose and terminal glucose carbohydrates that are commonly found in N-linked glycoproteins. In addition, ConA contains a binding site with an affinity for excessively hydrophobic proteins. WGA selectively binds terminal N-acetylglucosamine (O-GlcNAc) and sialic acid moieties characteristic of O-linked glycosylation. The addition of O-GlcNAc occurs in both secretory and nonsecretory O-linked glycosylation. Previous studies from our laboratory utilized ConA to fractionate proteins from MCI and AD hippocampus and inferior parietal lobule (IPL; Owen et al., 2009) . The current study explores the glycoproteome of MCI and AD hippocampus and IPL using WGA lectin affinity chromatography coupled to two-dimensional (2D) gel proteomics techniques.
MATERIALS AND METHODS Sample Preparation
Hippocampus and IPL samples (n 5 6 each) from wellcharacterized subjects with AD and MCI and age-matched controls (Table I) were obtained from the University of Kentucky Alzheimer's Disease Clinical Center Neuropathology Core. Samples were homogenized on ice with sucrose isolation buffer [0.32 M sucrose with protease inhibitors, 4 lg/ml leupeptin, 4 lg/ml pepstatin A, 0.125 M Tris, pH 8.0, 5 lg/ml aprotinin, 0.2 mM phenylmethylsulfonylfluoride (PMSF), and 0.6 mM MgCl 2 ]. Table I presents demographic data for the MCI and AD subjects. Note the very short post-mortem interval of these samples.
Protein estimation and WGA Lectin Affinity Columns
Protein concentrations were determined using the BCA method, and aliquots (1,500 lg) were diluted with 53 binding/ wash buffer in a 4:1 volumetric ratio and loaded into WGA affinity columns. WGA lectin columns, binding/wash, and elution buffers were prepared as described in the manufacturer's instructions (Pierce Biotechnology, Rockford IL). The samples were loaded onto columns and incubated for 10 min with endover-end mixing using an elliptical rotor. The samples were spun at 1,000g for 1 min, the effluent was reloaded onto the columns, and the process was repeated. The effluent was discarded after this step. Binding/wash buffer (400 ll) was added to the WGA lectin columns, and the columns then were centrifuged at 1,000g for 1 min, and the process was repeated. The columns were loaded with elution buffer (200 ll) and incubated for 10 min with end-over-end mixing using an elliptical rotor. The samples were spun at 1,000g for 1 min, and the effluent was retained. This process was repeated, and the elution buffers containing the WGA-associated proteins were combined (400 ll) and concentrated (to $ 25 ll) using 30-kDa cut-off filters (Millipore, Billerica MA). Protein concentration was redetermined using the BCA method, and the remaining aliquots were suspended in 200 ll of rehydration buffer composed of a 1:1 ratio (v/v) of the Zwittergent solubilization buffer (7 M urea, 2 M thiourea, 2% Chaps, 65 mM DTT, 1% Zwittergent 0.8% 3-10 ampholytes, and bromophenol blue) and ASB-14 solubilization buffer [7 M urea, 2 M thiourea 5 mM TCEP, 1% (w/v) ASB-14, 1% (v/v) Triton X-100, 0.5% Chaps, 0.5% 3-10 ampholytes] for 2 hr.
First-Dimension Electrophoresis
For the first-dimension electrophoresis, approximately 50 lg of protein in 200 ll of sample buffer was applied to 110-mm pH 3-10 ReadyStrip IPG strips (Bio-Rad, Hercules CA). The strips were then actively rehydrated in the protean isoelectric focusing (IEF) cell (Bio-Rad) at 50 V for 18 hr. The isoelectric focusing was performed at increasing voltages as follows; 300 V for 1 hr, then linear gradient to 8,000 V for 5 hr, and finally 20,000 V/hr. Strips were then stored at -808C until the second-dimension electrophoresis was performed.
Second-Dimension Electrophoresis
For the second dimension, the IPG strips, pH 3-10, were thawed and equilibrated for 10 min in 50 mM Tris-HCl (pH 6.8) containing 6 M urea, 1% (w/v) sodium dodecyl sulfate (SDS), 30% (v/v) glycerol, and 0.5% dithiothreitol, and then reequilibrated for 15 min in the same buffer containing 4.5% iodacetamide instead of dithiothreitol. Linear gradient precast criterion Tris-HCl gels (8-16%; Bio-Rad) were used to perform second-dimension electrophoresis. Precision Protein Standards (Bio-Rad) were run along with the samples at 200 V for 65 min.
Sypro Ruby Staining
After the second-dimension electrophoresis, the gels were incubated in fixing solution (7% acetic acid, 10% methanol) for 20 min and stained overnight at room temperature with 50 ml Sypro ruby gel stain (Bio-Rad). The Sypro ruby gel stain was then removed, and gels were stored in deionized water.
WGA Affinity Experiments
WGA glycoprotein affinity was tested by the addition of ethylenediamine tetracetic acid (EDTA; 500 mM) to column washing and elution buffers provided in the WGA lectin kit (Pierce Biotechnology). MCI age-matched control hippocampus samples were homogenized on ice with sucrose isolation buffer [0.32 M sucrose with protease inhibitors, 4 lg/ml leupeptin, 4 lg/ml pepstatin A, 0.125 M Tris, pH 8.0, 5 lg/ml aprotinin, 0.2 mM phenylmethylsulfonylfluoride (PMSF), 0.6 mM MgCl 2 , and 500 mM EDTA]. These samples underwent WGA column chromatography as described above. Protein fractions were loaded onto linear gradient 18-well precast criterion Tris-HCl gels (8-16%; Bio-Rad) and were used to perform one-dimensional electrophoresis. Precision Protein Standards (Bio-Rad) were run along with the sample at 120 V for 120 min. Gels were visualized using a STORM phosphoimager as described above.
Image Analysis
Sypro ruby-stained gel images were obtained using a STORM phosphoimager as indicated above and saved in TIFF format. Gel imaging was software-aided using PD-Quest (Bio-Rad) imaging software. Briefly, a master gel was selected, followed by normalization of all gels (control and AD or control and MCI) according to the total spot density. Gel to gel analysis was then initiated in two parts. First, manual matching of common spots that could be visualized among the differential 2D gels was performed. After obtaining a significant number of spots, the automated matching of all spots was then initiated. Automated matching is based on user-defined parameters for spot detection. These parameters are based on the faintest spot, the largest spot, and the largest spot cluster that occur in the master gel and are defined by the user. Based on these parameters, the software defines spot centers for the gel. If the software ''misses'' spots that are obvious to the naked eye, the user can manually assign a spot center. This process generates a large pool of data, approximately 350 spots. Only proteins showing computer-determined significant differential levels between the two groups being analyzed were considered for identification. To determine significant differential levels of proteins, analysis sets were created using the analysis set manger software incorporated into the PD-Quest software. The numbers of pixels that occur in a protein spot were computed by the software corresponding to an increase/decrease in protein level. A quantitative analysis set was created that recognized matched spots with differences in the numbers of pixels that occur in each spot, and a statistical analysis set was created that used a Student's t-test at 95% confidence to identify spots with P values of P < 0.05. Spots with P < 0.05 were considered significant. A Boolean analysis set was created that identified overlapping spots from the aforementioned quantitative and statistical sets. These spots were selected for subsequent mass spectrometric analysis.
In-Gel Trypsin Digestion
Protein spots statistically different from controls were digested in-gel by trypsin using protocols previously described and modified by Thongboonkerd et al. (2002) . Spots were taken from individual gels and were not pooled for mass spectrometric analysis. The amount of protein from one gel-spot is sufficient for identification. Briefly, spots of interest were excised using a clean blade and placed in Eppendorf tubes, which were then washed with 0.1 M ammonium bicarbonate (NH 4 HCO 3 ) at room temperature for 15 min. Acetonitrile was then added to the gel pieces and incubated at room temperature for 15 min. This solvent mixture was then removed, and gel pieces were dried. The protein spots were then incubated with 20 ll of 20 mM DTT in 0.1 M NH 4 HCO 3 at 568C for 45 min. The DTT solution was removed and replaced with 20 ll of 55 mM iodoacetamide in 0.1 M NH 4 HCO 3 . The solution was then incubated at room temperature for 30 min. The iodoacetamide was removed and replaced with 0.2 ml of 50 mM NH 4 HCO 3 and incubated at room temperature for 15 min. Acetonitrile (200 ll) was added. After 15 min of incubation, the solvent was removed, and the gel spots were dried in a flow hood for 30 min. The gel pieces were rehydrated with 20 ng/ll modified trypsin (Promega, Madison, WI) in 50 mM NH 4 HCO 3 with the minimal volume enough to cover the gel pieces. The gel pieces were incubated overnight at 378C in a shaking incubator.
All the mass spectrometry results reported in this study were obtained in collaboration with the Department of Pharmacology in the University of Louisville Mass Spectrometry Facility. Part of the results, MCI hippocampus and IPL, has been obtained using A Bruker Autoflex matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) coupled with the MASCOT search engine. The data from AD hippocampus and IPL were acquired using a Nanomate Orbitrap XL MS platform that generate MS/MS spectra analyzed using the SEQUEST database. The use of two mass spectrometers and databases for protein identification was due to the MALDI-TOF instrument being replaced by the Orbitrap instrument during the course of the project.
Mass Spectrometry 1
A Bruker Autoflex MALDI-TOF mass spectrometer in the reflectron mode was used to generate peptide mass fingerprints (Bruker Daltonic, Billerica, MA). Peptides resulting from in-gel digestion with trypsin were analyzed on a 384-position, 600-lm AnchorChip Target (Bruker Daltonics, Bremen, Germany) and prepared according to AnchorChip recommendations (AnchorChip Technology, Rev. 2, Bruker Daltonics, Bremen, Germany). Briefly, 1 ll of digestate was mixed with 1 ll of alpha-cyano-4-hydroxycinnamic acid (0.3 mg/ml in ethanol: acetone, 2:1 ratio) directly on the target and allowed to dry at room temperature. The sample spot was washed with 1 ll of a 1% TFA solution for approximately 60 sec. The TFA droplet was gently blown off the sample spot with compressed air. The resulting diffuse sample spot was recrystallized (refocused) using 1 ll of a solution of ethanol: acetone:0.1% TFA (6:3:1 ratio). Reported spectra are a summation of 100 laser shots. External calibration of the mass axis was used for acquisition and internal calibration using either trypsin autolysis ions or matrix clusters and was applied postacquisition for accurate mass determination. Peptide mass fingerprinting was used to identify proteins from tryptic peptide fragments by utilizing the MASCOT search engine based on the entire NCBI and SwissProt protein databases. Database searches were conducted allowing for up to one missed trypsin cleavage and using the assumption that the peptides were monoisotopic, oxidized at methionine residues, and carbamidomethylated at cysteine residues. Mass tolerance of 150 ppm, 0.1-Da peptide tolerance, and 0.2-Da fragmentation tolerance were the window of error allowed for matching the peptide mass values. Probability-based MOWSE scores were estimated by comparison of search results against estimated random match population and were reported as -10 Á log10 (p), where p is the probability that the identification of the protein is a random event. MOWSE scores greater than 63 were considered to be significant (P < 0.05). All protein identifications were in the expected size and isoelectric point (pI) range based on the position in the gel.
Mass Spectrometry 2
Protein spots of interest were excised and subjected to in-gel trypsin digestion, and resulting tryptic peptides were analyzed with an automated nanospray Nanomate Orbitrap XL MS platform. The Orbitrap MS was operated in a datadependent mode whereby the eight most intense parent ions measured in the FT at 60,000 resolution were selected for ion trap fragmentation with the following conditions: injection time 50 msec, 35% collision energy. MS/MS spectra were measured in the FT at 7500 resolution, and dynamic exclusion was set for 120 sec. Each sample was acquired for a total of $ 2.5 min. MS/MS spectra were searched against the ipi_Hu-man Database using SEQUEST with the following criteria: Xcorr > 1.5, 2.0, 2.5, 3.0 for 11, 12, 13, and 14 charge states, respectively, and P value (protein and peptide) < 0.01. IPI accession numbers were cross-correlated with SwissProt accession numbers for final protein identification.
Immunoprecipitation
For immunoprecipitation experiments, 150 lg protein extracts was suspended in 500 ll RIPA buffer (10 mM Tris, pH 7.6; 140 mM NaCl; 0.5% NP40 including protease inhibitors) and then incubated with 1 lg monoclonal antibody against 14-3-3g protein (wild-type-specific PAb11; Santa Cruz Biotechnology, Santa Cruz, CA) at 48C overnight. Immunocomplexes were collected using protein A/G suspension for 2 hr at 48C and washed five times with immunoprecipitation buffer. Immunoprecipitated 14-3-3g was recovered by resuspending the pellets in loading buffer, and protein was detected by Western blot.
Western Blot
Aliquots of the immunoprecipitated samples containing 50 lg of protein were added to sample buffer, denaturated for 5 min at 1008C, loaded on 8-16% precast Criterion gels (BioRad) and separated by electrophoresis at 100 mA for 2 hr. The gels were then transferred to nitrocellulose paper using the Transblot-BlotSD Semi-DryTransfer Cell at 20 mA for 2 hr. Subsequently, the membranes were blocked at 48C for 1 hr with fresh blocking buffer made of 3% bovine serum albumin (BSA) in phosphate-buffered saline containing 0.01% (w/v) sodium azide and 0.2% (v/v) Tween 20 (PBST). The membranes were incubated with anti-14-3-3g (Santa Cruz Biotechnology) primary antibody (1:1,000) for expression analysis and anti-b-O-linked N-acetylglucosamine (SigmaAldrich, St. Louis, MO) primary antibody (1:1,000) for glycosylation analysis in PBST for 2 hr with gentle rocking at room temperature. The membranes were then washed three times for 5 min each with PBST, followed by incubation with anti-mouse alkaline phosphatase or horseradish peroxidase-conjugated secondary antibody (1:3,000) in PBST for 2 hr at room temperature. Membranes were then washed three times in PBST for 5 min and developed using or 5-bromo-4-chloro-3-indolyl-phosphate/nitroblue tetrazolium (BCIP/ NBT) color developing reagent for alkaline phosphatase secondary antibody or ECL plus WB detection reagents for horseradish peroxidase-conjugated secondary antibody. Blots were dried and scanned in TIF format using Adobe Photoshop on a Canoscan 8800F (Canon) or STORM UV transilluminator (kex 5 470 nm, kem 5 618 nm; Molecular Dynamics, Sunnyvale, CA) for chemiluminescence. The images were quantified with ImageQuant TL 1D version 7.0 software (GE Healtcare).
Statistical Analysis
Statistical analysis of protein levels matched with spots on 2D gels from AD and MCI hippocampus and inferior parietal lobule compared with age-matched controls were carried out using Student's t-tests. A value of P < 0.05 was considered statistically significant (see above under Image analysis for generation of analysis sets). Only proteins that were considered significantly different by Student's t-test were subjected to ingel trypsin digestion and subsequent proteomic analysis. According to Maurer and Peters (2005) , generalized statistical tests that apply to proteomics studies are unavailable. Becauise of the small numbers of proteins that are typically identified in proteomics studies compared with microarray data, statistical methods applied to thousands of hits in microarray studies are not applicable for proteomics studies with relatively small numbers of identified proteins. Hence, Student's t-test was used for analysis (Boguski and McIntosh, 2003; Maurer and Peters, 2005) .
RESULTS

Column Specificity Experiment
The specificity of the WGA column for carbohydrate moieties was tested using EDTA to poison the column's lectin domain. The addition of EDTA to the equilibration and wash buffers used in the chromatography experiment successfully blocked protein binding of the lectin domain (Fig. 1) , indicating that nonspecific binding to the WGA column did not occur.
MCI vs CTR Hippocampus and IPL
Seven proteins with altered WGA affinity were identified in aMCI hippocampus, and one protein was altered in aMCI IPL compared with age-matched controls. -Fold change values are expressed as disorder (aMCI or AD) relative to age-matched control (CTR; e.g., 0.66-fold decrease of GP96 in MCI hippocampus signifies that the levels of GP96 WGA affinity is 0.66 times lower in MCI hippocampus than age-matched control. 14-3-3e Showed a 2.43-fold increase in WGA affinity and signifies that the level of 14-3-3e WGA affinity is 2.43 times higher in MCI hippocampus than age-matched control; see Table  II) . Compared with control, decreased WGA affinity in hippocampus was shown for GP96 (0.66-fold), glucosidase IIa (0.48-fold), and g-enolase (0.16-fold), whereas WGA affinity was significantly increased for 14-3-3e (2.43-fold), 14-3-3g (1.66-fold), glutamate dehydrogenase (11.5-fold), and tropomyosin 2 (2.30-fold; Table II, Fig. 2 ). Protein disulfide isomerase showed increased WGA affinity in aMCI IPL (2.16-fold) compared with age-matched controls (see Table II , Fig. 2 ).
AD vs. CTR Hippocampus and IPL
Nine proteins with altered WGA affinity were identified in AD hippocampus and two in AD IPL. 14-3-3f (2.07-Fold), tropomyosin 1 (2.08-fold), glutamate dehydrogenase (2.66-fold), a1-antichymotrypsin (5.50-fold), and N2,N2-dimethylguanosine tRNA methyltransferase (DMGtRNAMT; 1.70-fold) showed an increase in WGA affinity in AD hippocampus. In contrast, calmodulin Fig. 1 . EDTA-based column specificity 1D gel image. Lanes 1 and 2 are control samples treated with all buffers as described in Materials and Methods. Lanes 3 and 4 represent control samples in which all buffers described in Materials and Methods include 500 mM EDTA. EDTA acts as an inhibitor of lectin binding domains, and the resulting loss of signal shows that the WGA column binds proteins through the lectin binding domain with no nonspecific binding. Proteins of interest were identified using MASCOT database searches following MALDI-TOF mass spectrometry. Mowse scores are associated with protein identification using the MAS-COT database search algorithm. Scores >63 are considered significant.
2
Proteins of interest were identified using SEQUEST database searches following Orbitrap MS/MS mass spectrometry. The probability scores associated with protein identification using the SEQUEST search algorithm.
3
Fold changes are expressed as disorder (aMCI or AD) relative to age-matched control. (i.e., 0.66-fold decrease of GP96 in MCI hippocampus is equivalent to 44% of the degree of GP96 WGA affinity in MCI hippocampus than age-matched control. 14-3-3e Showed a 2.43-fold increase in WGA affinity and signifies that the degree of 14-3-3e WGA affinity is 2.43 times higher in MCI hippocampus than age-matched control).
4
The P value associated with the -fold changes observed between disorder and brain region with respect to appropriate nondemented age-matched controls using Student's t-test.
(0.50-fold), g-enolase (0.14-fold), gelsolin (0.44-fold), and b-synuclein (0.13-fold) were found with decreased WGA affinity in AD compared with CTR samples (Table II , Fig. 3 ). Both calreticulin (16.0-fold) and GP 96 (2.00-fold) showed an increase in WGA affinity in AD IPL in comparison with age-matched CTR samples (Table II , Fig. 3 ).
Confirmation of O-GlcNAc Glycosylation on 14-3-3c
To ascertain the implications of increased WGA affinity, a validation study on 14-3-3g glycosylation using traditional immunochemistry was performed. Western blot analysis showed that overall levels of 14-3-3g were not significantly different between CTR and MCI hippocampus (Fig. 4A) . However, increased levels of N-acetylglucosamine linked to the proteins in MCI sample vs. CTR, in agreement with the proteomic results, was observed (Fig. 4B) . Both techniques demonstrate that 14-3-3g is differentially glycosylated in MCI hippocampus, with an observed increase associated with this neurodegenerative disorder. This finding validates our proteomics analysis and indicates that the WGA affinity column binds proteins with increased glycosylation levels. Thus, the WGA column is sensitive to changes to the extent of protein glycosylation.
DISCUSSION
Hippocampal and IPL brain sections taken from subjects with aMCI, AD, and age-matched, nondemented controls were homogenized, and proteins were fractionated with WGA affinity chromatography. Subsequent WGA affinity protein fractions from the aforementioned groups were compared using 2D proteomics techniques to assess changes in proteins with altered WGA affinity levels. To clarify the implications of altered WGA affinity protein levels, the overall level of 14-3-3g and the level of N-acetylglucosamine linked 14-3-3g were measured using Western blots. The results indicate that the WGA column binds proteins with altered extents of glycosylation with higher affinity independently of over- Fig. 2 . Sypro-stained 4-16% polyacrylamide representative 2D gels of WGA-eluted proteins from MCI hippocampus and IPL and agematched control with statistically significant protein spot identities. For protein spot P values refer to Table II. Fig. 3 . Sypro-stained 4-16% polyacrylamide representative 2D gels of WGA-eluted proteins from AD hippocampus and IPL and agematched control with statistically significant protein spot identities. For protein spot P values refer to Table II. all protein level. The results of the 14-3-3g Western blot experiments also attest to WGA column affinity for N-acetylglucosamine carbohydrate moieties. Proteins found in the current study with altered WGA affinity encompass a broad range of functions, including chaperone, protein folding, glycoprotein maturation, metabolic, cytoskeletal and cytoskeletal maintenance, signaling, synaptic, secreted, and translational.
Chaperone and Glycoprotein Maturation Proteins
The ubiquitin/proteosome system (UPS), glucose metabolism, and Ca 21 homeostasis are disrupted in AD brain and are potent inducers of endoplasmic reticulum (ER) stress (Hoyer, 2004; Cecarini et al., 2007; Green, 2009) . Accumulating evidence suggests that ER stress and subsequent activation of the unfolded protein response (UPR) occur in AD brain (Hoozemans et al., 2005 (Hoozemans et al., , 2006 (Hoozemans et al., , 2009 . The UPR attenuates general protein synthesis followed by the up-regulation of chaperone proteins. The UPR will induce apoptosis if cellular homeostasis is not recovered (Vembar and Brodsky, 2008) . The ER-resident chaperone proteins calreticulin, GP96, and protein disulfide isomerase (PDI) and the ER-resident protein glucosidase II were identified in the current study with alterations in WGA affinity. Calreticulin, GP96, and PDI are integral to proper protein folding of maturing glycoproteins and to proteins retrotranslocated to the ER (Krebs et al., 2004; Wu et al., 2006; Issad and Kuo, 2008; Vembar and Brodsky, 2008) . GP96 is an HSP90 class chaperone protein but has an additional immunological role as an antigen-presenting molecule at the cell surface (Csermely et al., 1998 ). Also, the glycosylation level of GP96 has previously been reported to change as a function of cell stress and disease, including diabetes and cancer (Booth and Koch, 1989; Kang and Welch, 1991; Csermely et al., 1998) . PDI catalyzes proper disulfide bond formation during protein maturation and repairs nonnative disulfide bonds that form as a consequence of cellular stresses to mature proteins. PTMs to PDI have been previously shown to alter cellular homeostasis dramatically. PDI-nitrosylation in AD brain has been shown to inhibit PDI activity (Uehara et al., 2006) . In addition, PDI-nitrosylation leads to the accumulation of polyubiquitinated proteins and UPR activation (Uehara et al., 2006) .
Glucosidase II facilitates the entrance and exit of proteins into and out of the calreticulin/calnexin cycle, which is a glycoprotein quality-control mechanism. Maturing glycoproteins undergo the dynamic addition and removal of terminal glucose residues to and from their glycan moiety, with the removal of glucose catalyzed by glucosidase I and II. When maturing glycoproteins contain a solitary terminal glucose residue in the glycan moiety of the subject glycoprotein, the protein enters the calreticulin/calnexin cycle, facilitating protein folding (Vembar and Brodsky, 2008) . Once the glycoprotein reaches a properly folded conformation, glucosidase II trims the terminal glucose moiety of the glycan allowing the maturing glycoprotein to exit the calreticulin/calnexin cycle and proceed to the glycoprotein's appropriate destination.
Several ER-resident proteins found in the current study coupled with abundant literature relating these proteins to AD suggest that proteomics-identified ER proteins with altered WGA affinity play a role in ER stress observed in AD. Further studies are required to elucidate the implications of altered WGA affinity in AD, but we speculate that alterations in WGA affinity reflect these proteins' inability properly to bind target proteins and inhibit chaperone and glycosylation activities.
Metabolic Proteins
The current proteomics study identified two metabolic proteins with altered WGA affinity, g-enolase and glutamate dehydrogenase (GDH). g-Enolase is a neuronspecific glycolytic enzyme, but g-enolase has numerous functions in addition to glycolysis (Butterfield and Lange, 2009) . For example, g-enolase functions in neurons to regulate membrane-bound plasminogen, which is further cleaved to form plasmin (Butterfield and Lange, 2009) , with the latter shown to degrade both oligomeric and fibrillary Ab, thereby blocking Ab-induced neurotoxicity (Van Nostrand and Porter, 1999) . g-Enolase has previously been shown to be glycosylated, supporting the findings of the current study (Wells et al., 2002; Vosseller et al., 2005) .
GDH is integral to maintaining glutamate homeostasis and potentially plays a role in the glutamate induced excitotoxicity observed in AD. The observed decrease in the levels of g-enolase WGA affinity in MCI and AD hippocampus with the concomitant increase in GDH WGA affinity levels in both the aforementioned brain regions in the current study suggests a compensatory mechanism to cope with glucose metabolism deficits observed in AD brain. The changes observed in g-enolase and GDH WGA affinity correlate strongly with decreased glucose metabolism and excitotoxicity observed in AD and are consistent with elevated Ab in AD and MCI brain (Yamaguchi et al., 1997) .
Cytoskeletal and Cytoskeletal Maintenance Proteins
Oxidative PTMs to structural and cytoskeletal proteins and to proteins responsible for the maintenance and assembly dynamics of such proteins in axons and synapses have been hypothesized to play a role in the conversion of aMCI to AD (Butterfield and Sultana, 2007) . NFTs are composed of hyperphosphorylated tau, a microtubule-associated protein involved in microtubule assembly and stabilization. NFTs critically impair tau protein's ability to bind and stabilize microtubules disrupting the axonal cytoskeleton (Butterfield et al., 2006) . Cytoskeletal proteins found in this study with altered WGA affinity interact with tau or are associated with NFTs. Structural proteins identified in the present proteomics study with altered WGA affinity are 14-3-3g, 14-3-3e, and tropomyosin 1 in aMCI and tropomyosin 2, gelsolin, and 14-3-3f in AD.
14-3-3 Proteins modulate metabolic, apoptotic, cell cycle, and transcription factor proteins in myriad ways (Yaffe, 2002) . Previous studies on the localization and action of 14-3-3 in AD brain found that 14-3-3f is associated with NFTs and accelerates the PKA-catalyzed phosphorylation of tau, suggesting that 14-3-3f regulates microtubule assembly dynamics in the brain (Fu et al., 2000; Takahashi, 2003) . Aberrant expression of 14-3-3f, 14-3-3e, and 14-3-3g has been shown in the CNS throughout the progression of several neurodegenerative diseases, including AD (Fountoulakis et al., 1999; Peyrl et al., 2002) . The increased WGA affinity observed in the 14-3-3-class proteins identified in the current study may lead to conformational changes within the protein, modifying binding affinity and functionality, thereby providing potential mechanisms for studying the causality of aberrant 14-3-3 protein function observed in AD (Comer and Hart, 2000; Li and Paudel, 2007) .
Tropomyosin (TPM) stabilizes both muscle and nonmuscle cell actin filaments (Nyakern-Meazza et al., 2002) . Neuronal cells express a limited spectrum of TPM isoforms implicated in the differentiation and maturation of neurons as well as polarization of developing neurons, dendritic and axonal growth, and growth cone size and formation (Stamm et al., 1993; Gunning et al., 2008) . TPMs have been shown to be an integral components of NFTs in AD (Galloway et al., 1990) . Cytosolic gelsolin also interacts with actin, playing a role in modulating the length and number of actin filaments in neurons. TPMs and gelsolin work in concert to regulate microfilament assembly (Nyakern-Meazza et al., 2002) . TPMs are capable of annealing gelsolin-severed actin filaments and are efficient in converting gelsolin-actin complexes into long actin filaments (Nyakern-Meazza et al., 2002) . TPM and gelsolin levels increase during stress conditions in vitro and during AD progression, suggesting that both TPM and gelsolin are involved in the disease progression (Ji et al., 2009; Owen et al., 2009 ). The current study showed an increase in WGA affinity for TPM1 and TPM2 and a decrease in WGA affinity for gelsolin. This finding suggests that the balance of gelsolin-mediated actin severance and TPMmediated actin repair is altered in AD hippocampus. As noted above, alterations to cytoskeletal and cytoskeletal maintenance proteins observed in the current study with altered WGA affinity have also been well documented in the AD literature as being dysfunctional. The findings of the current study provide a rationale for new avenues of research to account for the differences observed in cytoskeletal and cytoskeletal maintenance proteins in AD brain.
Synaptic Proteins
b-Synuclein belongs to a family of highly homologous soluble proteins abundantly expressed in neurons at presynaptic terminals, particularly in the neocortex, hippocampus, striatum, thalamus, and cerebellum regions (George, 2002; Murphy et al., 2000) . Several lines of evidence suggest that b-synuclein acts as a chaperonelike protein in membrane-associated processes at the presynaptic terminal, possibly involving neurotransmitter vesicle docking to the presynaptic terminal (Boyd-Kimball et al., 2005) . b-Synuclein has decreased expression in AD brain and has been found to be linked to Ab in AD neurofibrillary lesions (Rockenstein et al., 2001) . b-Synuclein is glycosylated by a single O-GlcNAc moiety in rat synaptosomes (Cole and Hart, 2001; Boyd-Kimball et al., 2005) . The current study shows a modest decrease in WGA affinity of b-synuclein and may indicate that b-synuclein is less glycosylated in AD. However, the exact function of b-synuclein and the involvement of b-synuclein in AD remain to be elucidated.
Calcium Signaling Proteins
The calcium hypothesis of AD concerns disrupted intracellular Ca 21 homeostasis leading to neuronal dysfunction and ultimately apoptosis (Khachaturian, 1989) . Calmodulin (CaM) is an effector of calcium signaling and has a central role in neurodegenerative processes such as plasticity, learning, and memory (Klee et al., 1980; Sola et al., 1999) . CaM participates in synaptic function and neurotransmitter release, playing a role in Ca 21 -stimulated phosphorylation of synaptic proteins (Delorenzo et al., 1982) . In addition, CaM regulates the assembly and disassembly of microtubules (Marcum et al., 1978) . Altered WGA affinity of CaM in AD brain relative to age-matched controls might decrease CaM protein binding affinity, potentially disrupting regulatory mechanisms of Ca 21 signaling (Sacks et al., 1992; Quadroni et al., 1994) . Hence, altered WGA affinity of CaM in AD could be associated with altered CaM regulation of proteins.
Secreted and Translational Proteins
a1-Antichymotrypsin (ACT) is a secreted serine protease inhibitor and an acute-phase reactant protein (Ritchie et al., 2004; Licastro et al., 2005) . Several studies showed that ACT is found specifically in both amorphous and classic plaques in AD brain (Abraham and Potter, 1989a,b) . The presence of inflammatory proteins, including ACT, apolipoprotein E (ApoE), and complement in plaques led to the hypothesis that these proteins might serve to promote Ab polymerization and amyloid formation (Abraham et al., 1988; McGeer et al., 1989; . The impact of altered WGA affinity on ACT function in AD is not clear; however, changes in glycan composition might affect ACT's structure and localization and contribute to functional alterations of inflammatory proteins in AD.
N2,N2-dimethylguanosine tRNA methyltransferase (DMGtRNAMT) is an intracellular enzyme involved in the maturation of tRNA. Previous studies show alterations at the ribosome level in MCI and AD subjects, including decreased rate and capacity for protein synthesis, decreased ribosomal RNA and tRNA levels, and increased RNA oxidation (Ding et al., 2006) . Further studies are needed to understand the involvement of altered WGA affinity DMGtRNAMT in AD, but we speculate that such PTM differences in AD may be related to the altered protein synthesis reported to exist (Ding et al., 2006) .
SUMMARY
The altered WGA affinities of the proteins identified in the current proteomics study correlate strongly with previously established criteria and studies of glycosylation of these proteins. Also, as discussed above, most of the proteins found in the current study have been previously reported to be involved in pathways associated with cellular insults present in AD brain. Further characterization is needed to understand fully the implications of altered WGA affinity of these proteins, but a potential mechanism for further study is O-GlcNAcylation. The proteins found in the current study are all known to be phosphorylated and are localized in cytoplasmic, ER lumen, and the endomembrane system. To date, all known O-GlcNAc proteins are also phosphoproteins, suggesting that proteins identified in the current study are potentially modified by O-GlcNAc (Hart et al., 1996) . It is important to note that possibilities exist that proteins found in this study are modified by sialic acid or have an increased affinity for the WGA lectin binding domain; however, the findings in the current proteomics study correlate well with the established criteria for O-GlcNAcylation and the AD literature.
